Carlos Mena
@carlosmenayale
Associate Professor @
Director Vascular Medicine
VAMOS Program
@YNHH
ID: 3372501383
12-07-2015 16:15:52
1,1K Tweet
1,1K Followers
2,2K Following
Renal denervation therapy has a favorable safety profile with a very low incidence of major adverse events. ✍🏽 Keith C. Ferdinand, MD, FACC, FAHA, FNLA Carlos Mena Wanpen Vongpatanasin Olivia Blazek, MD Harini Sarathy Angela B Jennifer Cluett, MD Mu Huang, PhD, DPT Katherine Sheehan, PhD
Keith C. Ferdinand, MD, FACC, FAHA, FNLA Carlos Mena Wanpen Vongpatanasin Olivia Blazek, MD Harini Sarathy Angela B Jennifer Cluett, MD Mu Huang, PhD, DPT Katherine Sheehan, PhD 2/ Read more about the paper and supplemental materials here: spr.ly/6012Y1VK8
Wonderful piece. Amazing working with great group of talented scientist. Yale University Yale New Haven Hosp Yale School of Medicine Yale Internal Medicine Yale Department of Radiology & Biomedical Imaging Yale New Haven Hosp YaleVAMOS
A new study concludes renal denervation is an effective treatment option for patients with uncontrolled hypertension: medicine.yale.edu/news-article/a… Carlos Mena American Heart Association
"We have a lot of work to do to improve how we diagnose and treat #cardiovascular conditions in women." - samitshahmd Learn more about his research to help #women get the right #heart diagnosis and treatment: medicine.yale.edu/internal-medic…
Making milestones with the Cath Team at the VA CT led by samitshahmd and @pfausteve! First Drug-Coated Balloon treatment performed in Connecticut! Wonderful to offer this in-stent restenosis treatment to our amazing Veterans! Willington Amutuhaire. MD. MPH Jafar Alzubi
An American Heart Association statement co-authored by Yale Internal Medicine's Carlos Mena finds that #renal denervation, a catheter-based procedure that silences the renal nervous system, is an effective #treatment for many patients with #hypertension. brnw.ch/21wLNXU
Congrats!!! Super proud of you!!! Yale School of Medicine Yale New Haven Hosp Yale Cardiology
In a new Q&A, Carlos Mena Santiago Callegari Kim G. Smolderen, PhD discuss new research on factors impacting mortality for patients with chronic limb-threatening ischemia (CLTI) and the need to rethink the way to care for patients with CLTI. medicine.yale.edu/internal-medic…
A new statement by @American_Heartc concludes that renal denervation is an effective treatment for hypertension. Although, more research is required to better understand which patients may benefit most. Read more. Carlos Mena Yale Cardiology medicine.yale.edu/internal-medic…
Last year has been great Columbia Cardiothoracic Surgery NewYork-Presbyterian. Fantastic team and so many good people contributed to this accomplishment especially Michael LaLonde, OR robotic team, anesthesia, perfusion, outpatient APPs and office staff as well as my co-faculty. columbiasurgery.org/news/celebrati…
Excited to share our two research articles from the YaleVAMOS team now out in J Vascular Surgery!! Always grateful for the support and for learning every day from my mentors Kim G. Smolderen, PhD Carlos Mena Gaëlle Romain, PhD. Thankful every day to be training here at Yale Internal Medicine Yale IM Traditional Residency Program!
Happy to see our new article from the YaleVAMOS team out now in VascularMedicine!! All thanks to mentorship and guidance of Gaëlle Romain, PhD Kim G. Smolderen, PhD Carlos Mena Jacob Cleman Full article here ⬇️⬇️⬇️ journals.sagepub.com/doi/10.1177/13…
Patients with #PAD reporting lower levels of social support experience worse health outcomes, a new Yale-led study finds vascularnews.com/study-social-s… Yale School of Medicine J Vascular Surgery Kim G. Smolderen, PhD Carlos Mena Santiago Callegari
Online First! In this analysis, Santiago Callegari and colleagues at @YaleVamos compare competing risk analysis with standard time-to-event method to estimate the risk of major amputations in patients with peripheral artery disease undergoing intervention. buff.ly/3zgTRKp #PAD